Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
Azvudine은 COVID-19 환자 치료에 효과적인 흉선 유도 항 SARS-CoV-2 약물입니다.
Article
Published on
Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, SARS, 임상, 치료법, 치료제,
Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, SARS, 임상, 치료법, 치료제,
[키워드] (RdRp)
active form
agent
anti-SARS-CoV-2
Anti-SARS-CoV-2 Activity
Azvudine
cells
chest X-ray
clinical trial
compassionate use
coronavirus
COVID-19
COVID-19 patients
cured
Dizziness
Drug development
effective
followed by
Ground-glass opacities
ground-glass opacity
HCoV
HCoV-OC43
HIV-1
hospital discharge rate
Immunity
Infectious diseases
Inflammation
inhibit
inhibited
lymphocyte
mononuclear cell
mononuclear cells
monophosphate
nausea
Negative conversion
nucleoside
oral administration
organ damage
patients
PBMC
Peripheral blood
Peripheral blood mononuclear cells
phase
profiles
promoted
promotion
Randomized
RATs
RdRP
reduced
rhesus macaque
rhesus macaques
Ribonucleic acid
RNA polymerase
RNA-dependent RNA polymerase
SARS-CoV-2
selective
Sequencing
Side-effect
single-arm
suggested
thymus
treating
treating COVID-19 patient
Trial
triphosphate
Viral
Viral load
viral ribonucleic acid
virus
viruses
[DOI] 10.1038/s41392-021-00835-6 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41392-021-00835-6 PMC 바로가기 [Article Type] Article